Burgdorf, 4th July 2006, 7:30 a.m. – Ypsomed has resumed production of the dialling unit for the OptiClik® pen system as planned following an intensive optimisation phase. Matthew Robin, CEO of Ypsomed, explains: "The adjustments in the production have been successfully implemented, enabling Ypsomed to resume deliveries of newly produced OptiClik® pen systems to sanofi-aventis. We have also increased OptiSet® production at both the Burgdorf and Solothurn sites to 24 hours seven days a week." Production of the OptiClik® dialling unit had to be suspended for a total of eight weeks in order to carry out the technical adjustments to the manufacturing process.
Further information is available from Daniel Kusio, Head of Investor and Public Relations at Ypsomed Holding AG. Tel. +41 34 424 41 43 or Tel +41 34 424 41 11. This press release and further documents are available in electronic form at www.ypsomed.com.